| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
| mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
9e-05 |
| mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
| mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0003 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
| mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
| mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0005 |